Here is a link to the Ocata website, marking the start of a new era for what was formerly Advanced Cell Technology or ACT. It’s been a big summer for stem cell biotech Advanced Cell Technology (ACT; stock ACTCD) as it continues what I would call a process of reinventing itself. What’s been happening? ACT recently […]
ACT reinventing itself with new name Ocata Therapeutics Read More »
The reviews of a STAP paper submitted to and rejected by the journal Science in 2012 were posted at Retraction Watch yesterday. They filled in some gaps in the puzzle of the series of events that led to such flawed science being published in Nature in January 2014, but the reviews also raised more questions. Today, more STAP paper
STAP papers blistered by Nature’s own reviewers were then accepted Read More »
Before the two STAP cell papers were published in Nature in January of 2014, much of the same data was reportedly submitted as single papers to other high-profile journals including Science. In these cases, the proto-STAP papers as we might call them were rejected. But why? Until now we largely could only speculate. However, the reviews
Full Reviews of Rejected STAP Paper Point to Early Signs of Big Trouble Read More »
The last two years at Nature Magazine have seen a surprising wave of paper retractions. In 2013 and now just so far in 2014, Nature has retracted a total of 14 papers. How unusual is that? Historically, Nature retracts relatively few papers, perhaps just under two per year on average. What the heck has been going on in 2013-2014? Let’s break it
Could Nature’s 2-year torrent of paper retractions be a good thing? Read More »
Who should you follow on Twitter amongst all the biologists out there? Actually, it very much depends on your interests and what you want to get out of it. Below is my list of top biologists/biology writers that I, with all my many biases (see below) recommend to you to follow on Twitter, in no particular order (actually
A List of Top Biologists to Follow on Twitter Read More »
Nikkei is reporting that the RIKEN internal attempt to replicate so-called STAP (acid bath) cells has failed. Update: apparently, although RIKEN calls the efforts preliminary, the team tried to make STAP an amazing 22 times and 22 times it failed. The rumors for weeks in the stem cell gapevine that RIKEN itself could not get
RIKEN fails to reproduce STAP, big CDB shake up expected Read More »
What kind of scientist are you and do you engage in transactional science? I suspect that all of us scientists like to think that most of the work that we do is transformative and that we are a transformative scientist. In science we hear quite a lot about the importance of transformative, innovative science. But can
Is transactional science kicking transformative science’s butt? Read More »
Today has been a dark day of mourning for science following the death by suicide of Dr. Yoshiki Sasai. I did not know Dr. Sasai personally, but was very impressed with his work. His suicide leaves me feeling very sad and it seems like an appropriate time for reflection. (update I did a post on suicides by
Reflecting on Sasai tragedy, STAP, & flawed field of science Read More »
Many of this The Niche‘s readers ask about what my own lab’s research. What is the focus of the research of the Knoepfler Lab? You can go check out our lab website, but I thought it might be time to blog about what we are all about as a lab and what we have been
Knoepfler Lab: Our mission and research Read More »
I have been corresponding now and then with Dr. Teru Wakayama about the ongoing STAP situation. He asked me to pass along the following message from him for clarification on the STAP Nature paper retraction and the origin of the STAP stem cells (STAP-SC). I would like to take this opportunity to explain the reason for
New Message from Wakayama on STAP retraction & origin of STAP-SC Read More »